Article Text

Download PDFPDF

PO.2.31 Different patterns of longitudinal changes in antinuclear antibodies titres in children with systemic lupus erythematosus
  1. P Morán Álvarez,
  2. C Bracaglia,
  3. V Messia,
  4. I Caiello,
  5. F De Benedetti and
  6. E Marasco
  1. Division of Rheumatology, Ospedale Pediatrico Bambino Gesù ~ Rome ~ Italy


Purpose to investigate the trend of antinuclear antibodies (ANA) and anti-dsDNA autoantibodies titers over time in children with a diagnosis of systemic lupus erythematosus (SLE).

Methods We enrolled 15 children with a diagnosis of SLE, fulfilling the SLICC criteria. For all patients included in the study ANA and anti-dsDNA antibodies testing was carried out from diagnosis every 3–4 months for 2 years. ANA were defined as negative for titers lower than 1:80. Laboratory parameters, clinical and demographic data was retrieved and analyzed. Statistical analysis was performed with software R_v. 4.0.3.

Results Following two years of follow-up, all patients had ANA titers significantly lower than at time of SLE diagnosis (Mann Whitney test, p=0.0002) (figure 1A). After two years of follow-up, 11 patients (73%) still had positive ANA (group 1), while 4 patients (26%) had negative ANA (group 0). At time of diagnosis no significant differences in ANA titers (Mann Whitney test, p=0.74) (figure 1B) nor in disease activity, as measured by SLEDAI, (Mann Whitney test, p=0.88) were observed (table 1). No significant differences in organ involvement were observed (table 1). Assessing the change over time in ANA titers, the 2 groups of patients showed two different patterns: in group 0, ANA titers quickly declined and disappeared in the first 6 months after diagnosis; in group 1, ANA titers declined more slowly, remaining positive at 2-year follow-up (Figure 1C). Both C3 and C4 increased in the follow-up period, with no different patterns between the 2 groups (Figure 1C). Similarly, anti-dsDNA antibodies titers declined over time with no clear different patterns between the 2 groups (Figure 1C).

Abstract PO.2.31 Table 1

Conclusions Our analysis showed two different patterns in the reduction of ANA titers over time in patients with childhood onset SLE, with 26% of patients becoming ANA negative after 6 months from diagnosis and remaining persistently negative during follow-up. Our data have important implications, specifically for the recruitment of patients into clinical trials, where the latest classification criteria of SLE require ANA positivity as entry criterion. Moreover, a seronegative state may represent a different subcategory of patients with SLE with specific pathogenetic pathways involved, possibly independently from autoantibodies. Therefore, further studies are needed to confirm and expand our data.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.